Advertisement

NeuroPace raises $74 million to market seizure-monitoring device

NeuroPace raises $74 million to market seizure-monitoring device
From Reuters - October 24, 2017

(Reuters) - NeuroPace Inc said on Tuesday it raised $74 million in equity funding as the medical device maker looks to rapidly expand commercialization of its device to treat epileptic seizures.

The round of funding, led by the KCK Group and OrbiMed Advisors, is likely to be the Mountain View-based companys last as it plans to go public.

Our strategy is to take the company public, Chief Executive Frank Fischer told Reuters, hinting at a possible IPO by the second half of 2019.

Once implanted in the skull, NeuroPaces RNS System constantly monitors brain waves, identifying and disrupting unusual activity that may trigger seizures.

At least 3.4 million people in the United States suffer from epilepsy, according to the Centers for Disease Control and Prevention.

Advertisement

Continue reading at Reuters »